Patents by Inventor David Osborne

David Osborne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050186156
    Abstract: The present invention provides a method for protecting against UV radiation-induced skin damage. Specifically, compositions including dapsone are administered to provide UV protection. The dapsone compositions may be administered orally, or by other parenteral routes, such as topically, transdermally, by inhalation, and the like.
    Type: Application
    Filed: December 14, 2004
    Publication date: August 25, 2005
    Inventor: David Osborne
  • Publication number: 20050147658
    Abstract: The present invention relates to a pharmaceutical delivery device for application of a pharmaceutical to mucosal surfaces. The device comprises an adhesive layer and a non-adhesive backing layer, and the pharmaceutical may be provided in either or both layers. Upon application, the device adheres to the mucosal surface, providing localized drug delivery and protection to the treatment site. The kinetics of erodability are easily adjusted by varying the number of layers and/or the components.
    Type: Application
    Filed: March 1, 2005
    Publication date: July 7, 2005
    Inventors: Gilles Tapolsky, David Osborne
  • Publication number: 20050048102
    Abstract: The present invention relates to a pharmaceutical delivery device for application of a pharmaceutical to mucosal surfaces. The device comprises an adhesive layer and a non-adhesive backing layer, and the pharmaceutical may be provided in either or both layers. Upon application, the device adheres to the mucosal surface, providing localized drug delivery and protection to the treatment site. The kinetics of erodability are easily adjusted by varying the number of layers and/or the components.
    Type: Application
    Filed: October 12, 2004
    Publication date: March 3, 2005
    Inventors: Gilles Tapolsky, David Osborne
  • Publication number: 20050013845
    Abstract: The present invention provides bioerodible, water-soluble pharmaceutical carriers for ocular (e.g., transconjunctival or transcorneal) delivery of pharmaceuticals for either systemic or local therapy.
    Type: Application
    Filed: November 12, 2003
    Publication date: January 20, 2005
    Inventors: Stephen Warren, David Osborne, Richard Holl
  • Patent number: 6792766
    Abstract: A thermal zone demand controlled air conditioning fan coil unit using dual cascade arranged heat pumps, chilled water, or a combination of chilled water and hot water, with or without back up electric resistance heat strips, and having an air circulation system for circulating air to and from a plurality of thermal zones and including a conditioned air chamber having first and second heat exchange refrigerant coils or direct or reversed cycle water coils being connected in refrigerant circulating relation respectively with the heat pumps, chilled water coil. A plurality of thermal zone blowers conduct conditioned air from the conditioned air chamber to respective thermal zones of a building space. Electronic controller circuitry of the system is coupled for thermal demand control of the heat pumps and the thermal zone blowers for operation of the first heat pump during average thermal load and for operation of both heat pumps during greater thermal load.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: September 21, 2004
    Assignee: Cascade Manufacturing, L.P.
    Inventors: David Osborne, Brian Chester, Gary R. Scoggins
  • Publication number: 20040065095
    Abstract: A thermal zone demand controlled air conditioning fan coil unit using dual cascade arranged heat pumps, chilled water, or a combination of chilled water and hot water, with or without back up electric resistance heat strips, and having an air circulation system for circulating air to and from a plurality of thermal zones and including a conditioned air chamber having first and second heat exchange refrigerant coils or direct or reversed cycle water coils being connected in refrigerant circulating relation respectively with the heat pumps, chilled water coil A plurality of thermal zone blowers conduct conditioned air from the conditioned air chamber to respective thermal zones of a building space. Electronic controller circuitry of the system is coupled for thermal demand control of the heat pumps and the thermal zone blowers for operation of the first heat pump during average thermal load and for operation of both heat pumps during greater thermal load.
    Type: Application
    Filed: October 4, 2002
    Publication date: April 8, 2004
    Applicant: CASCADE MANUFACTURING, L.P.
    Inventors: David Osborne, Brian Chester, Gary R. Scoggins
  • Patent number: 6716546
    Abstract: A system 10 is provided for supplying air to a fuel cell 12 for use within a vehicle 14. The system 10 includes a conventional storage tank 16 which receives and stores hydrogen gas at a relatively high pressure, an expander unit 18, a compressor unit 20, pressure regulators 22, 24, a valve 26, a controller 30, and vehicle sensors 32, and a secondary compressor 34. The system 10 selectively channels pressurized hydrogen gas through expander unit 18 which lowers the pressure of the hydrogen gas and rotatably drives compressor 20. By utilizing the potential energy within the hydrogen gas to drive compressor 20, system 10 conserves energy and improves the overall fuel economy of the vehicle 14.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: April 6, 2004
    Assignee: Ford Motor Company
    Inventors: Keith Andrew Oglesby, Kurt David Osborne, Woong-chul Yang
  • Patent number: 6628006
    Abstract: A system 10 is provided for recovering the potential energy of a hydrogen gas fuel supply within a fuel cell powered vehicle 14. The system 10 includes a conventional storage tank 16 which receives and stores hydrogen gas at a relatively high pressure, an expander 18, a compressor 20, a motor/generator 76 which selectively generates electrical power and torque, pressure regulators 22, 24, a valve 26, an electrical charge storage device or battery 28, a controller 30, vehicle sensors 32 and electrical switches or switching module 34. The system 10 selectively channels pressurized hydrogen gas through expander 18 which lowers the pressure of the hydrogen gas, rotatably drives compressor 20 and generates electricity. Controller 30 causes the generated electricity to be selectively communicated to electrical accessories 72, and/or to battery 28 by use of switching module 34, based upon vehicle attribute data received from sensors 32.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: September 30, 2003
    Assignee: Ford Motor Company
    Inventors: Keith Andrew Oglesby, Kurt David Osborne, Woong-chul Yang
  • Publication number: 20030170177
    Abstract: The present invention pertains to microparticles of a lipid-binding protein such as defatted albumin or microparticles of such a protein having a non-natural lipid profile are useful in therapy, e.g., as a vehicle for gene therapy, and in imaging.
    Type: Application
    Filed: December 2, 2002
    Publication date: September 11, 2003
    Inventors: Roy Harris, Nicholas David Osborne
  • Patent number: 6591926
    Abstract: A system 10 is provided for recovering the potential energy of a hydrogen gas fuel supply within a fuel cell powered vehicle 14. The system 10 includes a conventional storage tank 16 which receives and stores hydrogen gas at a relatively high pressure, an energy conversion unit or assembly 18, a compressor unit or assembly 20, pressure regulators 22, 24, a valve 26, an electrical charge storage device or battery 28, a controller 30, vehicle sensors 32 and electrical switches or switching module 34. The system 10 selectively channels pressurized hydrogen gas through energy conversion unit 18 which lowers the pressure of the hydrogen gas and generates electricity. Controller 30 causes the generated electricity to be selectively communicated to compressor 20, electrical accessories 72, and/or to battery 28 by use of switching module 34, based upon vehicle attribute data received from sensors 32.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: July 15, 2003
    Assignee: Ford Motor Company
    Inventors: Keith Andrew Oglesby, Kurt David Osborne, Woong-chul Yang
  • Patent number: 6495527
    Abstract: Removal of lipid from lipid-bound protein such as human serum albumin to produce defatted protein enhances ability of the protein to bind therapeutic agents for use as a carrier for the therapeutic agent. The defatted protein may be reloaded with cationic and/or anionic lipids such as fatty acids, e.g. DC-Chol, to modify charge, hydrophilicity or hydrophobicity of the defatted protein to further enhance ability of the defatted protein to bind a therapeutic agent. A reloaded lipid itself may be a therapeutic agent. The defatted protein may be produced as microparticles by spray-drying. Defatting can be achieved by removing fatty acids with acidified activated charcoal, or by solvent extraction. A complex of DNA and a microparticle of defatted protein containing a cationic or anionic lipid molecule can be used for gene therapy. Defatted albumin may be reloaded with aminocaprylic acid to provide a microparticle for binding DNA for parenteral delivery.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: December 17, 2002
    Assignee: Quadrant Healthcare, Ltd.
    Inventors: Roy Harris, Nicholas David Osborne
  • Publication number: 20020162698
    Abstract: A system 10 is provided for recovering the potential energy of a hydrogen gas fuel supply within a fuel cell powered vehicle 14. The system 10 includes a conventional storage tank 16 which receives and stores hydrogen gas at a relatively high pressure, an energy conversion unit or assembly 18, a compressor unit or assembly 20, pressure regulators 22, 24, a valve 26, an electrical charge storage device or battery 28, a controller 30, vehicle sensors 32 and electrical switches or switching module 34. The system 10 selectively channels pressurized hydrogen gas through energy conversion unit 18 which lowers the pressure of the hydrogen gas and generates electricity. Controller 30 causes the generated electricity to be selectively communicated to compressor 20, electrical accessories 72, and/or to battery 28 by use of switching module 34, based upon vehicle attribute data received from sensors 32.
    Type: Application
    Filed: May 3, 2001
    Publication date: November 7, 2002
    Inventors: Keith Andrew Oglesby, Kurt David Osborne, Woong-Chul Yang
  • Publication number: 20020164515
    Abstract: A system 10 is provided for supplying air to a fuel cell 12 for use within a vehicle 14. The system 10 includes a conventional storage tank 16 which receives and stores hydrogen gas at a relatively high pressure, an expander unit 18, a compressor unit 20, pressure regulators 22, 24, a valve 26, a controller 30, and vehicle sensors 32, and a secondary compressor 34. The system 10 selectively channels pressurized hydrogen gas through expander unit 18 which lowers the pressure of the hydrogen gas and rotatably drives compressor 20. By utilizing the potential energy within the hydrogen gas to drive compressor 20, system 10 conserves energy and improves the overall fuel economy of the vehicle 14.
    Type: Application
    Filed: May 4, 2001
    Publication date: November 7, 2002
    Inventors: Keith Andrew Oglesby, Kurt David Osborne, Woong-chul Yang
  • Patent number: 6416739
    Abstract: Microcapsules having a wall thickness of no more than 500 nm, and a bulk density of no more than 0.2 g.cm−3, are suitable for therapeutic or diagnostic use. They are aerodynamically light, and can be used for delivery to the lung, or diagnosis by ultrasound.
    Type: Grant
    Filed: July 20, 2000
    Date of Patent: July 9, 2002
    Assignee: Quadrant Healthcare (UK) Limited
    Inventors: Cheryl Vanessa Rogerson, Nicholas David Osborne
  • Patent number: 6290594
    Abstract: A system 10 is provided for ventilating hydrogen gas from a vehicle 12 which includes one or more fuel cells 14. System 10 includes a control module or controller 16, vehicle sensors 20, several fans 22, and several hydrogen gas sensors 18 which are operatively and communicatively coupled to a hydrogen gas detection module 26. Hydrogen gas detection module 26, sensors 20 and fans 22 are each communicatively connected to controller 16. Controller 16 is effective to selectively and periodically activate fans 22 in response to signals received from module 26 (e.g., sensors 18) and sensors 20, thereby substantially preventing hydrogen gas from pocketing or collecting in areas of vehicle 12.
    Type: Grant
    Filed: August 16, 2000
    Date of Patent: September 18, 2001
    Assignee: Ford Global Tech., Inc.
    Inventor: Kurt David Osborne
  • Patent number: 4748717
    Abstract: A hinge is disclosed which has a barrel 12 which is screw threaded at least at its ends. A grub screw 16 is inserted into one end of the barrel and can be screwed into and out of the barrel to adjust the relative height of a pin 22 inserted into the barrel to enable the height of a gate to be adjusted. The hinge can be used as a left or right hand hinge by simply inverting the hinge and screwing the grub screw 16 into the appropriate end of the hinge. An intermediate element 70 may be included to adjust for misalignment of the gates. The intermediate element has an eccentric bore 73 and the element can be rotated within the barrel 12 and locked to the pin 22 to adjust the pivot point of the pin 22 in the barrel 12 and thereby adjust for any misalignment of the hinge.
    Type: Grant
    Filed: October 14, 1986
    Date of Patent: June 7, 1988
    Assignee: Highland Bond Pty. Ltd.
    Inventor: David Osborne